NeoStem, Inc. (Nasdaq:NBS), a biopharmaceutical company developing novel cell based therapies, announced today that the Company and its subsidiary, Progenitor Cell Therapy, LLC, will present at multiple upcoming conferences in December.
http://bit.ly/1rNBI7X
No comments:
Post a Comment